October 21, 2026 | BIX 2026 Is Almost Here 🇰🇷

Issue #58 · October 21

View Archive | Subscribe | Partners With Us

From Members to Global: Covering the Entire Bio Industry

BIX 2026: The Countdown Is On!⏰

Happy Wednesday! With BIX 2026 just around the corner, Korea’s biotech industry is gearing up for its next phase of growth. Samsung Bioepis has secured a 10-year biosimilar supply deal in Brazil, while Vaxcellbio reported a 69% response rate in a small liver cancer trial. Read on for the latest from K-Bio! 🚀

THIS WEEK:

BIX 2026 kicks off on October 28, spotlighting growth strategies for space biopharmaceuticals and companies

BioPlus-Interphex Korea 2026 (BIX 2026) has unveiled key programs focused on space biopharmaceuticals and growth strategies for biotechnology companies. — THE BIO

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

Samsung Bioepis said Tuesday it has secured a 10-year deal to exclusively supply its rare disease biosimilar SB12 to Brazil's public health system, strengthening its foothold in Latin America's largest pharmaceutical market. — The Korea Herald

Vaxcellbio's NK cell therapy shows 69% response rate in small liver cancer trial

Vaxcellbio's experimental natural killer (NK) cell therapy, VCB-1102, combined with hepatic arterial infusion chemotherapy (HAIC), achieved an objective response rate (ORR) of 68.75 percent in a single-arm phase 2a trial involving 16 patients with locally advanced liver cancer. — KBR

KoreaBIO MEMBER NEWS

Neurophet Wins Two Awards at BioSpectrum Asia Excellence Awards 2026
IVIM Technology Makes First Global Move Following CRO Restructuring at BioJapan 2026
CAPSTONE BRIDGE Conducts Needs Assessment Survey for Gangnam Severance Hospital
MicroDigital to Showcase CELBIC Cell Culture Food Production Equipment at K-FOOD Gyeongbuk 2026
Oscotec Revamps Official Website to Strengthen Communication with Investors and Partners

👥 View More Members Companies

#Member #Benefits

⭐ Exclusive Lounge for KoreaBIO Member Companies at BIX 2026!

◆ LOCATION
THE PLATZ, 2F · Next to the Registration Desk · Booth O01

◆ OPEN DAILY DURING BIX 2026
October 28 (Wed) - 30 (Fri)

10:00 AM - 5:00 PM

☕ Coffee & Refreshments — Enjoy complimentary coffee, beverages, and snacks.

🤝 Networking & Business Meetings ㅡ Connect with fellow KoreaBIO members.

🛋️ Private Relaxation Space ㅡ Take a break in a comfortable, members-only setting.

🌸 AI-Powered Perfume Experience ㅡ Create your own personalized scent with AI.

📸 BIX Photo Booth ㅡ Capture fun, unforgettable moments at BIX!

KoreaBIO members are welcome to enjoy our exclusive lounge.

STOP BY, RELAX & MAKE THE MOST OF YOUR BIX EXPERIENCE!

REAL INNOVATION GLOWS IN THE DARK

🔗 Read More

Here's what's happening across Korea's bio industry!

WHAT'S HAPPENING

INNOVATION & TRENDS

∎ The Race to Copy the World’s Best-Selling Cancer Drug Is Heating Up - The Korea Bizwire
∎ Can South Korea Weather the Endurance Test of Late-Stage Development? - The Asia Business Daily
∎ Cosmax Expands Joint Research with Harvard Hospitals into Health Functional Foods and New Drug Development - The Asia Business Daily
∎ GC Biopharma, LG CNS Build AI Smart Factory - The Chosun Daily
∎ Korea designates 8 more essential medicines for newborns, cancer patients - KBR
∎ Korean OB-GYNs back GLP-1 drugs for women with obesity planning pregnancy - KBR
∎ Researchers in South Korea use gene editing to produce soyabean with more than 90% oleic acid - Oils & Fats International
∎ Researchers in Korea explore use of smartphones to help detect lung problems in children - BioSpectrum Asia

GROWTH & PERFORMANCE

∎ Cell Biotech's Duolac probiotics shown to improve chronic kidney disease in mechanism study - The Herald Business
∎ CJ Bioscience partners with The Way Healthcare on personalized microbiome business - The financial news
∎ Daewoong Pharmaceutical Builds Dedicated Microneedle Plant in Korea - Seoul Economic Daily
∎ Macrogen adopts Roche's AXELIOS 1 to cut genome sequencing time - KBR
∎ Neurophet Honored with Two Awards at the BioSpectrum Asia Excellence Awards 2026 - PR Newswire
∎ Samsung Bioepis' first ADC drug candidate wins US FDA Fast Track designation - MoneyToday
∎ The six award-winning companies of the first Prix Galien Korea showed the strength and diversity of Korea's innovation ecosystem - Maeil Business

📰 View Latest KoreaBIO News

EDITOR'S NOTE

REAL INNOVATION GLOWS IN THE DARK

Looking for the must-attend sessions at BIX 2026?🔎

From radiopharmaceuticals and space-enabled biopharma to the post-GLP-1 obesity market and why great deals fall apart, explore the key topics and challenges across the biotech and biopharma industries at BIX 2026.

Check out our featured sessions, explore the full conference program, and plan your BIX 2026 schedule!

📅 October 28–30, 2026 | COEX, Seoul

🔗 View the Full Conference Program